PCG
RDY icon

Private Capital Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Private Capital Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1K Sell
110
-1,105
-91% -$12K ﹤0.01% 1764
2022
Q1 		$14K Hold
1,215
– – ﹤0.01% 1159
2021
Q4 		$16K Hold
1,215
– – ﹤0.01% 1131
2021
Q3 		$16K Buy
1,215
+5
+0.4% +$67 ﹤0.01% 1171
2021
Q2 		$18K Hold
1,210
– – ﹤0.01% 1147
2021
Q1 		$15K Hold
1,210
– – ﹤0.01% 1176
2020
Q4 		$17K Hold
1,210
– – ﹤0.01% 1241
2020
Q3 		$17K Buy
1,210
+5
+0.4% +$60 ﹤0.01% 1154
2020
Q2 		$13K Hold
1,205
– – ﹤0.01% 1257
2020
Q1 		$10K Buy
1,205
+5
+0.4% +$42 ﹤0.01% 1279
2019
Q4 		$9K Sell
1,200
-5
-0.4% -$39 ﹤0.01% 1370
2019
Q3 		$9K Buy
1,205
+20
+2% +$149 ﹤0.01% 1500
2019
Q2 		$8K Sell
1,185
-4,660
-80% -$36.6K ﹤0.01% 1483
2019
Q1 		$47K Buy
5,845
+2,150
+58% +$16.3K 0.01% 806
2018
Q4 		$28K Buy
3,695
+2,500
+209% +$17.6K 0.01% 944
2018
Q3 		$8K Buy
1,195
+10
+0.8% +$67 ﹤0.01% 1557
2018
Q2 		$7K Hold
1,185
– – ﹤0.01% 1556
2018
Q1 		$8K Buy
1,185
+110
+10% +$771 ﹤0.01% 1461
2017
Q4 		$8K Buy
+1,075
New +$7.74K ﹤0.01% 1465

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Private Capital Group's RDY Position: Q2 2022 in Review

Private Capital Group reduced its Dr. Reddy's Laboratories (RDY) stake by 91% in Q2 2022, selling an estimated $12K and leaving 110 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

Private Capital Group first reported a position in RDY in Q4 2017 and has held it in 19 quarters since. The position peaked at $47K in Q1 2019. 148 funds tracked by Wall St. Rank hold RDY as of Q2 2022.

  • Private Capital Group held 110 shares of Dr. Reddy's Laboratories worth $1K as of Q2 2022.
  • Private Capital Group sold 1,105 Dr. Reddy's Laboratories shares in Q2 2022, an estimated $12K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1764 holding.
  • Private Capital Group first reported a position in Dr. Reddy's Laboratories in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Dr. Reddy's Laboratories position peaked at $47K in Q1 2019.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.